Turkish Journal of Veterinary & Animal Sciences
Volume 43

Number 6

Article 16

1-1-2019

Phenotypic characterization and differentiation of mesenchymal
stem cells originating from adipose tissue
ECE ÇERÇİ
HATİCE ERDOST

Follow this and additional works at: https://journals.tubitak.gov.tr/veterinary
Part of the Animal Sciences Commons, and the Veterinary Medicine Commons

Recommended Citation
ÇERÇİ, ECE and ERDOST, HATİCE (2019) "Phenotypic characterization and differentiation of mesenchymal
stem cells originating from adipose tissue," Turkish Journal of Veterinary & Animal Sciences: Vol. 43: No.
6, Article 16. https://doi.org/10.3906/vet-1810-61
Available at: https://journals.tubitak.gov.tr/veterinary/vol43/iss6/16

This Article is brought to you for free and open access by TÜBİTAK Academic Journals. It has been accepted for
inclusion in Turkish Journal of Veterinary & Animal Sciences by an authorized editor of TÜBİTAK Academic
Journals. For more information, please contact academic.publications@tubitak.gov.tr.

Turkish Journal of Veterinary and Animal Sciences

Turk J Vet Anim Sci
(2019) 43: 834-845
© TÜBİTAK
doi:10.3906/vet-1810-61

http://journals.tubitak.gov.tr/veterinary/

Research Article

Phenotypic characterization and differentiation of mesenchymal stem cells originating
from adipose tissue
Ece ÇERÇİ, Hatice ERDOST*
Department of Histology and Embryology, Faculty of Veterinary Medicine, Uludağ University, Görükle, Bursa, Turkey
Received: 23.10.2018

Accepted/Published Online: 26.09.2019

Final Version: 03.12.2019

Abstract: Stem cells are known as undifferentiated cells that are capable of divisions and self-renewal over an extended period. Adipose
tissue-derived mesenchymal stem cells (ADSCs) are known to differentiate into many different organ and tissue cells. The purpose
of this study was to characterize adipose tissue-derived mesenchymal stem cells in detail based on the expression status of certain
surface markers and differentiation stages for clinical and laboratory applications. The migrating phase and mitotic property of the cells
from adipose tissue were assessed under a microscope. Cell counting was performed during the first, second, and third passages. The
cells were differentiated into osteogenic, chondrogenic, and adipogenic lineages. Stem cells were characterized by immunostaining of
CD90, CD105, CD11b, and CD45 surface markers. ADSC growth kinetics were determined at the first, second, and third passages. In
conclusion, ADSCs were reported in detail here based on surface markers and differentiation potentials, growth curves, and population
doubling times during the first, second, and third passages.
Key words: ADSCs, differentiation, characterization, growth curve, population doubling time

1. Introduction
Isolation techniques for adipose cells from rat tissue were
pioneered by Rodbell in the 1960s [1]. Mesenchymal stem
cells (MSCs) can be isolated from mammalian animal
tissues such as tendon, synovial membrane, bone marrow,
liver, dental pulp, adipose tissue, placenta, amniotic fluid,
and amniotic cord blood [2]. The isolation procedure for
stem cells from adipose tissue is relatively less invasive
compared to that for bone marrow-derived mesenchymal
stem cells (BMSCs) [3]. The International Society of
Cellular Therapy (ISCT) defined that MSCs must be able
to be differentiated into at least three lineages (osteoblast,
chondroblast, and adipocyte cells). Also, they must have
the capacity to attach to plastic surfaces for in vitro
cultivation [4].
MSCs are characterized by the presence or absence of
certain surface markers [4]. Adipose-derived stem cells
(ADSCs) are characterized by the expression of certain
stem cell surface markers such as CD105, CD90, CD73,
and CD44 and the lack of CD45, CD34, CD14, and CD11b
expression. ADSCs have some advantages over other
multipotent stem cell types, including accessibility to fat
tissue and faster proliferation capability [5,6].
The purpose of this study is to describe the details
of the steps for isolation of mesenchymal stem cells,

characterization with surface markers, differentiation
potentials, growth curves, and population doubling times
during the first, second, and third passages for tissue
engineering and regenerative medicine, especially in cases
of limited starting material.
2. Materials and methods
2.1. Animals
Ethical approval was received from the Uludağ University
Local Ethics Committee of Animal Experiments (201507/01). Four Sprague Dawley rats of 3 months old were
used for fat tissue collection.
2.2. Isolation and culturing of ADSCs
Prior to initiating this experimental protocol, rats’ fur
was wetted with 70% ethanol (Cat. No: 65350-M; Merck,
Germany). After the tissue sample transferring phase from
the normal laboratory to a cell culture laboratory, tissue
samples were immediately rinsed with sterile D-PBS
10 times in a separate sterile plastic cell culture plate
(Millipore, Germany; Cat. No: BSS-1006). Approximately
1.5 g of adipose tissue per rat was collected from the
abdominal and subcutaneous fat under sterile conditions.
The nonenzymatic culture method was used for the
isolation of ADSCs [6].
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Adipose tissue fragments were then minced in
thicknesses of 3–4 mm and transferred to rat MSCspecific growth medium (Cyagen, USA; Cat. No:
RAXMD-03011-440). Growth medium contained 100
units/mL penicillin, 100 µg/mL streptomycin (GIBCO,
Ireland; Cat. No: TMS-AB2-C), 2 mM L-glutamine
(GIBCO; Cat. No: G7513), and 20% heat-inactivated fetal
bovine serum (GIBCO; Cat. No: TMS-013-B). Tissue
fragments were incubated in tissue culture flasks of 25
cm2 under standard culture conditions (5% CO2, in a
humidified air atmosphere of 96%, at 37 °C). The culture
medium was replaced with fresh medium once every three
days to avoid possible differentiative effects of various
cytokines originating from the MSCs and to restore
nutrient depletion.
2.3. Cell counting and population doubling time
Trypan blue staining was performed to analyze the cell
viability at passage 1 (P1), passage 2 (P2), and passage
3 (P3). For counting, a 1:1 ratio was used (100 µL cell
suspension with 100 µL of trypan blue). Cell solution (10
µL) was added to Thoma slides during the subculturing
periods of P1, P2, and P3.
Population doubling time (PDT) is defined as the
time in which the number of cells doubles in a culture.
Viable cells were counted using an inverted microscope to
determine growth kinetics and cells were seeded per 35mm2 cell culture plate.
The population doubling number (PDN) and PDT
were calculated using the following equations:
PDT = CT / PDN,
PDN = log (N/ N0) × 3.31,
where CT is time of cultivation between days, N is cell
number at the end of the cultivation period, and N0 is cell
number at culture initiation [5]. In the second equation,
N and N0 are numbers of cells at the end and beginning of
the culture period, respectively. In this study the culture
period of P1, P2, and P3 counted to determine proliferation
potential for determining PDT was seven days.
2.4. Multilineage differentiation of adipose-derived stem
cells
2.4.1. Osteogenic differentiation
ADSCs (6 × 104 cells/cm2) were seeded in 24-well culture
plates. MSCgo Osteogenic Differentiation Medium
(Biological Industries, Israel; Cat. No: 05-440-1B) was
added when cells reached 80% confluency. The P3 cell
osteogenic differentiation medium was replaced with a
fresh portion. The medium was then replaced every 2–3
days. The cultures were examined and photographed
under an inverted microscope (Nikon-Eclipse). After 21
days, cells were stained with Alizarin red [7].
2.4.2. Chondrogenic differentiation
ADSCs (1 × 106 cells/cm2) were seeded in 96-well culture
plates. MSCgo Chondrogenic Differentiation Basal

Medium (Biological Industries; Cat. Nos: 05-220-1B and
05-221-1D) was added when cells reached 80% confluency.
The P3 chondrogenic differentiation medium was replaced
with a fresh portion. The medium was then replaced every
2–3 days. The cultures were examined and photographed
under an inverted microscope (Nikon-Eclipse). Cells were
incubated in the chondrogenic medium for 21 days and
stained with Alcian blue [7].
2.4.3. Adipogenic differentiation
ADSCs (6 × 104 cells/cm2) were seeded in 24-well plates. The
standard medium was replaced with MSCgo Adipogenic
Differentiation Basal Medium (Biological Industries; Cat.
Nos: 05-330-1B, 05-331-1-01, and 05-332-1-15) when
cells reached 80% confluency. The P3 cell culture medium
was replaced with a fresh portion. The medium was then
replaced every 2–3 days. The cultures were examined and
photographed under an inverted microscope (NikonEclipse). After two weeks the cells were stained with Oil
red O [7]
2.5. Characterization of ADSCs by immunohistochemistry
P3 ADSCs were detached using trypsin/EDTA 0.02%
(PAN-Biotech, Germany; Cat. No: P10-019100) and were
counted. Forty thousand ADSCs (cells/cm2) were seeded
on 8-well plastic culture slides for immunostaining and
transferred to a CO2 incubator for cell adhesion (standard
conditions: 5% CO2, 37 °C, 96% humidity) for 24 h. The
cells were fixed with 4% paraformaldehyde (Merck; Cat.
No: 1.04005.1000) for 1 h at room temperature and then
with methanol for 15 min at –20 °C. Cells were rinsed
with phosphate-buffered saline (PBS) (Sigma, USA; Cat.
No: P4417-100TAB) four times. Cells were permeabilized
with Triton-X 100 (Sigma; Cat. No: T8787) for 10 min and
rinsed with PBS. Afterwards, these cells were incubated
for 10 min with 3% hydrogen peroxidase and then rinsed
with PBS. A blocking step was performed for 5 min at
room temperature. The cells were incubated with CD90
(1:700 dilution; Abcam, UK; Cat. No: ab225), CD105
(1:100 dilution; Abcam; Cat. No: ab156756), CD45 (1:200
dilution; Abcam; Cat. No: ab8879), and CD11b (1:200
dilution; Abcam; Cat. No: ab10558) stem cell surface
primary antibodies for 18 h at 4 °C in a humidity chamber.
The cells were then incubated with secondary antibody
(Thermo Scientific, USA; Cat. No: TP-125-HL) for 10
min and streptavidin-peroxidase solution was added
for 10 min. Finally, the bound antibody complexes were
stained with chromogen solutions for 3–5 min and then
counterstained with hematoxylin.
2.6. Statistical analyses
For growth curves and population doubling times, cell
numbers were expressed as mean ± SE. Cell viability was
analyzed using t-tests and PDN and PDT analyzed using
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ANOVA. All statistical analyses were carried out using
SPSS 23.
3. Results
ADSCs at P1 exhibited a migration phase from adipose
tissue in the isolation phase (Figures 1A and 1B),
P1 exhibited a fibroblast-like morphology under the
microscope (Figures 1C and 1D), and ADSCs at P2
exhibited confluency (Figures 1E and 1F). ADSCs at P3
exhibited a flattened, fibroblast-like morphology with
regular cytoplasm and increased proliferation potential
(Figure 1G) compared to P1 and P2. Cells at P3 appeared
to consist of a more homogeneous population than the
cells at P1 and P2 (Figure 1H). Cell numbers of ADSCs
isolated from 1.5 g of adipose tissue were 8 × 106, 30 × 106,
and 22 × 106 at P1, P2, and P3, respectively (Table 1).
In P1, after cell confluency in four T25 flasks, 8 × 106
cells/cm2 were obtained (cell density: 2.1 × 106 cells/cm2,
2.2 × 106 cells/cm2, 1.8 × 106 cells/cm2, and 1.9 × 106 cells/
cm2).
In P2, after cell confluency in two T25 flasks and three
T75 flasks, 30 × 106 cells/cm2 were obtained (cell density:
2.5 × 106 cells/cm2, 2.5 × 106 cells/cm2, 8.3 × 106 cells/cm2,
8.4 × 106 cells/cm2, and 8.3 × 106 cells/cm2).
In P3, after cell confluency in one T25 flask and three
T75 flasks, 22 × 106 cells/cm2 were obtained (cell density: 2
× 106 cells/cm2, 6.7 × 106 cells/cm2, 6.5 × 106 cells/cm2, and
6.8 × 106 cells/cm2).
In this study, the osteoblastic morphology of ADSCs
at P3 was first noticed on the 14th day (Figures 2A and
2B). Development of mineralized extracellular and cellular
matrix nodules in these cells continued from day 5 until
day 21 (Figure 2C). Osteoblasts were detected using
Alizarin red staining on day 21 (Figure 2D).
The chondrogenic morphology of ADSCs at P3 was
noticeable starting on day 14 in the present study (Figures
3A and 3B). The Alcian blue staining confirmed the
presence of proteoglycans, suggesting the formation of
cartilage matrix on day 21 (Figures 3C and 3D).
The differentiation of ADSCs at P3 into adipocytes was
confirmed by the presence of prominent lipid droplets.
The cells undergoing adipogenic differentiation started
to exhibit a vacuolar morphology on day 5. Fat cells were
detected by Oil red O staining on day 14 (Figures 4A–4D).
ADSCs were negative for hematopoietic markers CD11b
and CD45 (Figures 5A–5D), while they were positive for
mesenchymal surface markers CD90 and CD105 (Figures
6A–6D) as assessed by immunohistochemical analyses.
Growth curve analyses were performed for seven
consecutive days for P1, P2, and P3 cells. The mean
values of viable cells at P1, P2, and P3 were 591 ± 22.01,
646.42 ± 57.96, and 723.57 ± 42.5, respectively (Table 2).
In the subculture period, while there were no significant
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differences in cell numbers between P1 and P2, there were
higher numbers of cells at P3 than P1 (P < 0.05) (Table
2; Figure 7A). However, P2 cells exhibited a faster growth
pattern compared to P1 and P3 cells based on logarithmic
growth curve analysis (P < 0.05) (Figure 7B). The P2 cells
had faster proliferation capacity compared to P1 and
achieved faster confluence. The cell population doubling
number (PDN) was calculated for all three passages. The
PDN was significantly lower for P2 cells as compared to P1
and P3 cells (P < 0.001) (Table 3; Figure 7C). Accordingly,
P2 cells displayed a higher PDT as compared to P1 and P3
cells (P < 0.01) (Table 4; Figure 7D).
4. Discussion
MSCs are not subjected to the same constraints as
embryonic stem cells and ADSCs can be noninvasively
obtained from adipose tissue [6–8]. MSCs have a large
number of cell sources and they are known as a suitable
population for the use of clinical or research studies in
human and animal science [9–15]. Nancy et al. [6] showed
that nonenzymatic isolation results in a substantially
higher yield of ADSCs at isolation phase per gram of
initial adipose tissue. In the present study, ADSCs that
were isolated using the nonenzymatic method exhibited
faster proliferative and migration properties (P1). Bonab
et al. [12] showed that the first, second, and third passages
of cells derived from bone marrow lasted for 15, 10, and
12 days, respectively. Our study showed that the first,
second, and third passages of cells derived from adipose
tissue lasted for 8, 13, and 18 days, respectively. Niyaz et
al. [16] used a nonenzymatic technique and three male
Wistar albino rats for cell isolation but there were no data
shown for the rats’ ages. Their results showed that after 7
days only fibroblast-like cells were detected and complete
confluence was not exhibited in 6-well cell culture plates.
In the present study we used 3-month-old male Sprague
Dawley rats and T25 flasks for isolation of cells. First
complete confluence was shown on day 8. Niyaz et al. [16]
noted the isolation of primary cells similarly to our results
in accordance with complete cell confluence time. On day
8, we obtained complete confluency, which may be related
to types of cell culture plates, genotypes of rats, ages of rats,
and cell culture and laboratory techniques.
Özen et al. [17] showed that ADSCs obtained by
the nonenzymatic method had higher affinity to plastic
surfaces and exhibited faster proliferative capacity, as well
as accelerated disappearance of erythrocytes from culture.
Our results were similar to those of Özen et al. [17]
regarding the proliferative potential and homogeneity of
the cell population. Lendeckel et al. [18] noted that ADSCs
have more proliferative capacity than BMSCs, particularly
those from pediatric patients: 295 million mononuclear
cells were expanded from 42.3 g of adipose tissue and

ÇERÇİ and ERDOST / Turk J Vet Anim Sci

Figure 1. A) ADSCs started to exhibit migration phase from adipose tissue in isolation phase (arrows) (bar: 100 µm). B) Fibroblast-like
cell (arrow) (bar: 25 µm). C) Primary passage confluency (arrow) (bar: 100 µm). D) ADSCs exhibited fibroblast-like cell morphology
at P1 (arrow) (bar: 25 µm). E) ADSCs started to reach confluence at P2 (bar: 100 µm). F) ADSCs at P2 exhibited confluency (bar: 25
µm). G) ADSCs at P3 exhibited a flattened, fibroblast-like morphology with regular cytoplasm (arrows) (bar: 100 µm). H) Cells at P3
appeared to consist of a more homogeneous cell population (bar: 25 µm).
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Table 1. Cell numbers in P1, P2, and P3 from 1.5 g of adipose
tissue-derived mesenchymal stem cells.
T25
culture flask

T75
culture flask

Total cell
number

P1 cell number

4

-

8 × 106

P2 cell number

2

3

30 × 106

P3 cell number

1

3

22 × 106

approximately 2%–3% of these cells were assumed to be
stem cells in enzymatic isolation. In our study 22 million
cells in P3 were isolated from 1.5 g of adipose tissue.
In the work of Halvorsen et al. [19], stromal cells were
trypsinized and plated in multiple-well plates at 3 × 104 cells/
cm2, but we used 6 × 104 cells/cm2 to allow for attachment
in stromal media. We found that, during osteogenic
differentiation, the fibroblast-like phenotype of P3 cells was
first noticed on day 14 and differentiation into osteoblastic

Figure 2. A, B) P3 ADSCs started to exhibit osteoblastic morphology on day 14 (thin arrows). C, D) Extracellular
calcium deposition and osteoblastic morphology as demonstrated by positive Alizarin red S staining on day 21
(thick arrow) (bar: 25 µm).
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Figure 3. A, B) P3 ADSCs started to exhibit chondroblastic morphology and accumulate proteoglycan aggregates
on day 14 (arrows). C, D) Staining of chondroblast precursor cell by alcian blue (arrows and *) (bar: 25 µm).
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Figure 4. A, B) P3 ADSCs started to exhibit adipocyte cell morphology (arrows) with lipid droplets on day 6
(arrows). C, D) Vacuolar cell membrane of adipocytes (arrows) stained with Oil red O on day 14 (bar: 25 µm).
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Figure 5. P3 ADSCs did not express CD11b (A, B) or CD45 (C, D) surface markers, as assessed by
immunohistochemistry (bar: 25 µm).
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Figure 6. P3 ADSCs expressed CD90 (A, B) and CD105 (C, D) surface markers, as assessed by
immunohistochemistry (bar: 25 µm).
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Table 2. Cell counts and mean values of P1, P2, and P3 cells
throughout seven days (total cell count: ×104 cells/mL).
P1 viable cells

P2 viable cells

P3 viable cells

1st day

520,000

425,000

900,000

2nd day

540,000

450,000

800,000

3rd day

615,000

630,000

800,000

4th day

625,000

700,000

690,000

5th day

687,000

750,000

660,000

6th day

600,000

760,000

585,000

7th day

550,000

810,000

630,000

Mean values

591 ± 22.01

a

646.42 ± 57.96 723.57 ± 42.5b

indicate statistically significant differences for values on the
same line, P < 0.05.
a, b

cells was completed in 21 days. Activation of stem cells is
critical in the generation of osteocytes. In this study, a specific
osteogenic differentiation medium was used. Halvorsen et
al. [19] demonstrated an increase in osteocalcin secretion

during the osteogenic differentiation phase from day 3 until
day 18. Microscopically, we observed the accumulation
of mineralized matrix nodules starting on day 7, which
continued to increase until day 21. Mineralized matrix
nodule appearance and Alizarin red staining indicated an
osteoblast pattern resembling that observed by Halvorsen et
al. [19].
In a study conducted by Yoshimura et al. [20], 8 × 105
cells were cultured and differentiated into chondroblasts
using a pellet culture system in 21 days, while in our study,
in accordance with that of Kim et al. [21], 1 × 106 ADSCs
cells were seeded for the chondrogenic differentiation phase.
In most studies [15–19,22,23], the differentiation of
ADSCs into adipocytes was completed in a maximum of
14 days. In that of Halvorsen et al. [19], 3 × 104 cells/cm2
were cultured and differentiated into adipocytes, but we
used 6 × 104 cells/cm2 for adipogenic differentiation, as did
Baker et al. [24]. Subsequently, ADSCs were differentiated
into adipocyte precursor cells, confirmed by the presence
of prominent neutral lipid droplets. ADSCs started to
develop vacuolar cellular formations within 5 days and full
differentiation was completed in 14 days.

Figure 7. A) Total cell count of P1, P2, and P3 cells. B) Growth curve analyses of P1, P2, and P3 cells. C) Population doubling number
(PDN) analyses of P1, P2, and P3 cells. D) Population doubling time (PDT) analyses of P1, P2, and P3 cells.
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Table 3. The cell population doubling number values in P1, P2, and P3 cells
throughout seven days. PDN value: log 10 (q). Total cells were counted within 1
mL; PDT and PDN calculated for intervals of 24, 48, 72, 96, 120, 144, and 168 h.
P1 PDN values

P2 PDN values

P3 PDN values

1st day

0.790423243

0.500019369

1,215948099

2nd day

0.844951992

0.176091259

1.51057157

3rd day

1.03190528

0.322219295

1.480093084

4th day

1.052789639

0.255272505

0.996409286

5th day

1.191055447

0.397940009

0.728557771

6th day

0.996409286

0.380211242

0.922674419

7 th day

0.844951992

Mean values

0.965 ± 0.0542

a, b

0.431363764
a

0.868713107

0.352 ± 0.0415

1.103 ± 0.115a

b

indicate statistically significant differences for values on the same line, P < 0.001.

Table 4. Cell population doubling time (PDT) values in P1, P2, and P3 cells throughout
seven days.
P1 PDT values

P2 PDT values

P3 PDT values

1st day

30

47

19

2nd day

56

272

31

3rd day

69

223

48

4th day

91

376

96

5th day

100

301

164

6th day

144

378

156

7 th day

198

389

Mean values

98.28 ± 21.49

a, b

a

284.42 ± 45.91

101 ± 26.68 a

indicate statistically significant differences for values on the same line, P < 0.01.

ADSC characterization has been reported in many
studies and by the ISCT [3,4,16,17,22]. ADSC populations
have been shown to express ≥95% CD73, CD90, and CD105
and to lack hematopoietic markers CD45 and CD11b
[10,16,19,25–29]. In accordance with the published data,
ADSCs in this study were positive for CD90 and CD105
and negative for CD45 and CD11b surface markers as
assessed by immunohistochemistry. In our study, we
showed that expression patterns of cell surface markers
on P3 cells were associated with MSCs [28–30]. El Atat et
al. [31] reported that ADSCs displaying CD90 and CD105
expressions were able to adhere to plastic surfaces under
in vitro culture conditions. Moreover, these markers have
also been used to determine multilineage differentiation
capabilities of ADSCs [30]. The minimum homogeneity of
MSCs was observed as 98.68% positive for CD29, CD90,
CD54, and MHC Class I by flow cytometry analysis [16].
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In our study, we used CD90 and CD105 positive markers,
and CD90 was strongly positive compared to CD105
immunohistochemically. Similar results were shown by
Niyaz et al. [16].
Our study revealed that about 22 million ADSCs
of P3 were isolated from 1.5 g of adipose tissue. This
is necessary for tissue engineering and regenerative
medicine, especially in cases of limited starting material.
In conclusion, ADSCs’ isolation, characterization,
differentiation, growth curves, and population doubling
times were reported here in detail to contribute to the
literature knowledge.
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